Renal Cell Carcinoma: Evolving Perspectives on Optimal Treatment

Learn how to align your clinical practice with guideline-concordant care in renal cell carcinoma—from identifying those patients who are most likely to benefit from targeted and immunotherapy to selecting the optimal treatment based on disease-related and patient-related factors—through an expert-curated, downloadable slideset.

Share

Program Content

Activities

RCC Treatment
Renal Cell Carcinoma: Evolving Perspectives on Optimal Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 19, 2024

Expires: August 18, 2025

Faculty

cover img faculity

Katy Beckermann, MD, PhD

Assistant Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Eric Jonasch, MD

Professor, Department of GU Medical Oncology
UT MD Anderson Cancer Center 
Houston, Texas

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Supporters

This activity is supported by educational grants from AVEO Pharmaceuticals, Inc. (“AVEO Oncology, an LG Chem company”) and Eisai. This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

AVEO Pharmaceuticals, Inc.

Eisai

Merck & Co., Inc.

Partners

Clinical Care Options, LLC

ProCE Banner